Abstract
The European Union's Falsified Medicines Directive, which came into force on 9 February, has laid down rigorous rules for pharmaceutical companies and pharmacists to follow in a bid to eradicate the pernicious impact of fake drugs infiltrating the legal supply chain. Joy Ogden reports on the progress so far.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
